Effect of thromboxane A2 (TXA2 ) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs Source: Eur Respir J 2001; 18: Suppl. 33, 264s Year: 2001
PGD2 induces constriction of the peripheral guinea pig lung via the TP receptor Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2 Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Discovery of competitive thromboxane receptor (TP) antagonism by diclofenac in guinea pig airway and vascular tissues Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology Year: 2007
Modulation of antigen- and serotonin-induced airway contractions in rat precision cut lung slices by prostaglandin E2 Source: Eur Respir J 2007; 30: Suppl. 51, 714s Year: 2007
Antigen-induced formation of prostaglandin D2 in mouse asthma model Source: Eur Respir J 2005; 26: Suppl. 49, 578s Year: 2005
A novel protective role of prostaglandin D2 in antigen-induced bronchoconstriction Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
A novel TRPA1 antagonist inhibits ovalbumin-induced bronchoconstriction in guinea pig models Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019
The effects of PGD2 and DK-PGD2 on features of airway remodeling in human airway epithelial cells and guinea pig lung slices Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
COX-1 driven biosynthesis of PGD2 during activation of human mast cells prevents formation of other prostanoids Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Source: Eur Respir J 2006; 27: 944-950 Year: 2006
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Prostaglandin D2 (PGD2 ) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Alpha-1L, but not alpha-1H, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 104s Year: 2001
Increased COX-1 and COX-2 mRNA expression and prostaglandin E2 production by dendritic cells from patients with asthma Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production Year: 2003
Effects of iNOS inhibition on nNOS expression in inflammatory and bronchial epithelial cells in guinea pigs with chronic lung inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 344s Year: 2005
The β-adrenoceptor antagonist propranolol induced Ca2+ mobilisation and enhanced contractile responses in guinea pig airways, in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 190s Year: 2002
Oral administration of a new prostacyclin agonist with thromboxane synthase inhibitory activity improves bleomycin-induced lung fibrosis Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010
Effects of acute nitric oxide synthase inhibition in a model of chronic airway inflammation in guinea pigs: correlation with capsaicin pretreatment Source: Eur Respir J 2002; 20: Suppl. 38, 383s Year: 2002
Effects of thromboxane A2 receptor antagonists on airway mucus overproduction induced by cigarette smoke and lipopolysaccharide Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009